Augmenting Drug Discovery with AI

This event was mistakenly linked to from the April 2024 Oxford MedSci Newsletter. If you are interested in attending the New Therapeutic Approaches in Translational Mental Health Conference on 16 November 2024, please use this link: https://talks.ox.ac.uk/talks/id/c13f06f7-216b-4371-85cd-18d85117e9be/.

Casper is the founder and CEO of Abzu®, the Danish/Spanish startup that builds trustworthy AI to tackle complex challenges for the world’s leading companies. Casper is the inventor of the QLattice® symbolic AI algorithm, an explainable AI that rationally reasons and makes evidence-based decisions. He has 20+ years of experience building large scale systems for data processing, analysis, and AI, and is passionate about the impact of AI on knowledge work and the intersection of AI with philosophy and ethics.

Date: 17 November 2023, 12:00
Venue:
Innovation Building
See location on maps.ox

Details: Ground floor seminar room. Seminar is followed by a networking lunch.
Speakers: Speaker to be announced
Organising department: Medical Sciences Office
Organisers: Sheena Lee (MSD Business Partnerships Office), Medical Sciences Division Business Partnerships Office (University of Oxford)
Organiser contact email address: sheena.lee@medsci.ox.ac.uk
Host: Dr Charlotte Bell (Industry Partnerships Manager, University of Oxford)
Part of: Industry Insight Seminar Series
Booking required?: Required
Booking url: https://www.eventbrite.co.uk/e/industry-insights-seminar-series-tickets-131313804123
Cost: Free
Audience: Members of the University of Oxford and the UK Biotech/Pharma industry
This talk features in the following public collections:
Editor: Sheena Lee